Critical Care Medicine Doctors in White Plains, NY Accepting Medicare

5 Critical Care Medicine doctors found. Showing 1 - 5

Richard Bruce Frimer, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 170 Maple Ave, Suite G1, White Plains, NY 10601 Phone: 914-683-0443    Fax: 914-683-8620

Dr. Emanuel Ira Wurm, DO Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-6511    Fax: 914-682-6403

Dr. Steven M. Meixler, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-6532    Fax: 914-682-6403

Nelky Esther Ramirez, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 41 E Post Rd, White Plains, NY 10601 Phone: 914-681-1174

Andrew Michael Goldstein, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 170 Maple Ave, Suite 208, White Plains, NY 10601 Phone: 914-683-0443    Fax: 914-683-8620

News Archive

Promising new treatment for hereditary breast/ovarian cancer

European scientists recently discovered a novel therapy to treat a subgroup of patients with hereditary breast/ovarian cancer. Both the EU and the US have approved an accelerated procedure to market this promising new treatment with few side effects.

IRB Barcelona scientists develop new drug target to prevent muscle deterioration in certain diseases

​In the study published today in the Journal of Clinical Investigation (JCI), one of the journals with highest impact in experimental medicine, the researchers associate the activity of the DOR protein with muscle atrophy and point to DOR as a plausible target against which to develop a drug to prevent muscle deterioration in certain diseases.

Most refractory status epilepticus patients have poor functional outcome

Three-quarters of refractory status epilepticus patients have a poor functional outcome, which is linked to drug-induced coma and severe encephalographic suppression, say US scientists.

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.

Read more Medical News

› Verified 6 days ago